Active surveillance in intermediate-risk prostate cancer with PSA 10–20 ng/mL: pathological outcome analysis of a population-level database

BACKGROUND: Active surveillance (AS) is generally recognized as the preferred option for men with low-risk prostate cancer. Current guidelines use prostate-specific antigen (PSA) of 10–20 ng/mL or low-volume biopsy Gleason grade group (GG) 2 as features that, in part, define the favorable intermedia...

Descripción completa

Detalles Bibliográficos
Autores principales: Lonergan, Peter E., Jeong, Chang Wook, Washington, Samuel L., Herlemann, Annika, Gomez, Scarlett L., Carroll, Peter R., Cooperberg, Matthew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705238/
https://www.ncbi.nlm.nih.gov/pubmed/34508180
http://dx.doi.org/10.1038/s41391-021-00448-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705238/
https://www.ncbi.nlm.nih.gov/pubmed/34508180
http://dx.doi.org/10.1038/s41391-021-00448-8

Ejemplares similares